Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.0307478148.2943
Domestic EquitiesPiramal Pharma Ltd.5.89772169884.8768
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.2887135484.3732
Domestic EquitiesArtemis Medicare Services Ltd.5.08611537964.2057
Domestic EquitiesGlenmark Pharmaceuticals Ltd.4.5872246143.7931
Domestic EquitiesCipla Ltd.4.2560244023.5193
Domestic EquitiesDivi's Laboratories Ltd.3.925356203.2458
Domestic EquitiesAlkem Laboratories Ltd.3.783764093.1287
Domestic EquitiesAbbott India Ltd.3.70779983.0659
Domestic EquitiesSyngene International Ltd.3.5679406262.9503
Domestic EquitiesApollo Hospitals Enterprise Ltd.3.519843992.9105
Domestic EquitiesGlobal Health Ltd.3.5065241972.8995
Domestic EquitiesNavin Fluorine International Ltd.3.486868472.8832
Domestic EquitiesIPCA Laboratories Ltd.3.4318188942.8377
Domestic EquitiesDr Agarwal's Health Care Ltd.3.3553622302.7745
Domestic EquitiesNeuland Laboratories Ltd.3.289122532.7197
Domestic EquitiesOnesource Specialty Pharma Ltd.3.1258147512.5847
Domestic EquitiesMankind Pharma Ltd.3.1183106342.5785
Domestic EquitiesAurobindo Pharma Ltd.3.0284215792.5042
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.2.9880152222.4708
Domestic EquitiesVinati Organics Ltd.2.8405148572.3488
Domestic EquitiesZydus Lifesciences Ltd.2.7915260412.3083
Domestic EquitiesConcord Biotech Ltd.2.2686111621.8759
Domestic EquitiesMetropolis Healthcare Ltd.2.2288117801.8430
Domestic EquitiesLaurus Labs Ltd.1.9578263931.6189
Domestic EquitiesSuven Pharmaceuticals Ltd.1.9397139351.6039
Domestic EquitiesSanofi Consumer Healthcare India Ltd.1.020917490.8442
Total 98.0286 81.0594
Cash & Cash Equivalents and Net AssetsTreps2.9443 2.4346
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.9729 -0.8045
Total 1.9714 1.6301
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.